Drugs / calcimycin
calcimycin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial · 1 met primary | ||||||
| — | NCT02424214 | Apr 2015 → Jan 2016 | infertility disorder | Ibn Sina Hospital | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT06106412 Comparator | Jan → Dec 2024 | female infertility | Instituto Valenciano de Infertilidad, IVI VALENCIA | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | calcimycin | “Artificial oocyte activation with SrCl2 or calcimycin after ICSI improves clinical and embryological outcomes compared with ICSI alone” PMID 30099496 ↗ Sep 20181“the use of calcium ionophores such as ionomycin and A23187 (calcimycin) predominates” NCT06106412 ↗ |
| Known as | A23187 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06106412 ↗ |
| Known as | ANTIBIOTIC A-23187 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1256686 ↗ |
| Modality | Small molecule | — CHEMBL1256686 ↗ |